Jump Financial LLC Increases Stock Position in Alignment Healthcare, Inc. (NASDAQ:ALHC)

Jump Financial LLC increased its position in Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) by 31.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 105,200 shares of the company's stock after acquiring an additional 25,200 shares during the period. Jump Financial LLC owned about 0.05% of Alignment Healthcare worth $1,184,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the company. Rhumbline Advisers boosted its stake in shares of Alignment Healthcare by 2.2% during the 4th quarter. Rhumbline Advisers now owns 135,704 shares of the company's stock worth $1,527,000 after acquiring an additional 2,937 shares during the last quarter. Alliancebernstein L.P. raised its holdings in Alignment Healthcare by 2.8% in the 4th quarter. Alliancebernstein L.P. now owns 119,440 shares of the company's stock worth $1,344,000 after purchasing an additional 3,300 shares during the period. R Squared Ltd purchased a new position in Alignment Healthcare during the fourth quarter valued at $55,000. SG Americas Securities LLC grew its holdings in Alignment Healthcare by 11.7% during the fourth quarter. SG Americas Securities LLC now owns 49,272 shares of the company's stock valued at $554,000 after purchasing an additional 5,163 shares during the period. Finally, Barclays PLC increased its position in Alignment Healthcare by 3.7% in the fourth quarter. Barclays PLC now owns 200,564 shares of the company's stock worth $2,256,000 after buying an additional 7,118 shares in the last quarter. Hedge funds and other institutional investors own 86.19% of the company's stock.

Insiders Place Their Bets

In other Alignment Healthcare news, CEO John E. Kao sold 90,000 shares of the stock in a transaction on Tuesday, February 11th. The stock was sold at an average price of $14.23, for a total value of $1,280,700.00. Following the sale, the chief executive officer now owns 2,183,100 shares in the company, valued at $31,065,513. This trade represents a 3.96 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, President Dawn Christine Maroney sold 30,000 shares of the company's stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $13.72, for a total transaction of $411,600.00. Following the completion of the transaction, the president now owns 1,576,097 shares in the company, valued at approximately $21,624,050.84. The trade was a 1.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 2,156,855 shares of company stock valued at $34,744,307 over the last three months. 6.60% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on ALHC. Barclays boosted their price objective on Alignment Healthcare from $8.00 to $9.00 and gave the company an "underweight" rating in a research note on Friday, February 28th. Stephens reissued an "overweight" rating and issued a $17.00 price objective on shares of Alignment Healthcare in a research note on Monday, February 24th. William Blair restated an "outperform" rating on shares of Alignment Healthcare in a research report on Friday, February 28th. Stifel Nicolaus increased their price target on Alignment Healthcare from $18.00 to $23.00 and gave the stock a "buy" rating in a research note on Tuesday, April 8th. Finally, Piper Sandler boosted their price objective on Alignment Healthcare from $14.00 to $21.00 and gave the company an "overweight" rating in a research report on Tuesday, March 4th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $16.61.

Alignment Healthcare Trading Down 3.0 %

Shares of NASDAQ:ALHC traded down $0.54 during trading on Friday, hitting $17.50. The company had a trading volume of 2,174,458 shares, compared to its average volume of 1,707,507. The stock has a market cap of $3.36 billion, a price-to-earnings ratio of -22.73 and a beta of 1.32. The company has a debt-to-equity ratio of 1.82, a current ratio of 1.60 and a quick ratio of 1.60. The company has a fifty day simple moving average of $16.87 and a two-hundred day simple moving average of $14.04. Alignment Healthcare, Inc. has a one year low of $5.02 and a one year high of $21.06.

Alignment Healthcare Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.